Article info

other Versions

PDF
Reflections on using non-inferiority randomised placebo controlled trials in assessing cardiovascular safety of new agents for treatment of type 2 diabetes

Authors

  1. Correspondence to Dr Denise Campbell-Scherer
    , Alberta Diabetes Institute, Clinical Research Unit, 2-004 Li Ka Shing Ctr, 87 Ave and 112 St. Edmonton, Alberta T6G 2E1, Canada; denise.campbell-scherer{at}ualberta.ca

Citation

Campbell-Scherer D
Reflections on using non-inferiority randomised placebo controlled trials in assessing cardiovascular safety of new agents for treatment of type 2 diabetes

Publication history

  • Published in print 7 March 2017.
  • Published online 8 March 2017.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.